Patiromer Acetate Induced Hypercalcemia: An Unreported Adverse Effect.

Author: BhattaraiShreeyukta, Man Singh DangolGulshan, PupilloStephen, SaracErdal

Paper Details 
Original Abstract of the Article :
Hyperkalemia, a potential life threating condition, is a commonly encountered problem in chronic kidney disease (CKD) patients. Patiromer acetate, a nonabsorbable cation exchange polymer, is a gastrointestinal agent for chronic therapy in patients with persistent hyperkalemia. Patiromer is generally...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6378798/

データ提供:米国国立医学図書館(NLM)

Patiromer Acetate: A Potential Cause of Hypercalcemia

Hyperkalemia is a condition characterized by high levels of potassium in the blood. Patiromer acetate is a medication used to treat hyperkalemia. This case report describes an unexpected side effect of patiromer acetate: hypercalcemia, a condition characterized by high levels of calcium in the blood. The authors report a case of a patient with stage IV chronic kidney disease (CKD) who developed hypercalcemia while taking patiromer acetate. The authors highlight the potential for patiromer acetate to cause hypercalcemia, a side effect that has not been previously reported in major clinical trials. This case report underscores the importance of monitoring calcium levels in patients taking patiromer acetate.

Patiromer Acetate: A Double-Edged Sword?

The case report raises concerns about the potential for patiromer acetate to cause hypercalcemia. While patiromer acetate is generally well-tolerated, this case highlights the importance of monitoring calcium levels in patients taking this medication.

Navigating the Treatment of Hyperkalemia

This case report emphasizes the importance of carefully monitoring patients taking medications to treat hyperkalemia. It's crucial for healthcare providers to be aware of potential side effects and to take appropriate measures to ensure patient safety.

Dr. Camel's Conclusion

This case report serves as a valuable reminder of the importance of vigilance in medicine. While patiromer acetate is a helpful medication for treating hyperkalemia, this case report underscores the need for careful monitoring of patients to ensure their safety and well-being.

Date :
  1. Date Completed n.d.
  2. Date Revised 2020-10-01
Further Info :

Pubmed ID

30863649

DOI: Digital Object Identifier

PMC6378798

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.